Delivery Order SPE2DR25D3201-SPE2DR26FT6HL
- Not listed
- The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200 mg/ml Benlysta auto-injector medication on January 9, 2026, with completion targeted for February 2, 2026. The award was made on a non-set-aside, competitive basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,973.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on January 15, 2026, with an ultimate completion date of February 6, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded under full and open competition. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used primarily to treat...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml auto-injector on January 16, 2026, with an ultimate completion date of February 9, 2026. This competitively awarded, non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on February 3, 2026, with completion scheduled for February 25, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $9,248.01 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used to treat systemic lupus erythematosus and other...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 11, 2025, with completion targeted for January 5, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used in the treatment of systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency awarded a $6,973.34 delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 23, 2026, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of February 13, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under the...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT6HLDelivery Order
The Defense Logistics Agency awarded a $13,946.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on February 3, 2026, with an ultimate completion date of February 25, 2026. This contract was awarded on a non-set-aside, competitive basis and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. Benlysta is a biologic immunosuppressant medication used to treat systemic lupus erythematosus, a condition that affects military-connected populations including active duty service members and veterans. The delivery order reflects AmerisourceBergen's established role as a critical pharmaceutical vendor within the federal medical supply chain, leveraging its extensive inventory and distribution capabilities to fulfill specialized medication requirements across the Defense Health Agency and related military treatment facilities. The firm fixed-price structure and streamlined delivery timeline demonstrate the efficiency of the IDC vehicle in enabling rapid procurement of essential pharmaceutical commodities to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 2/2/26 |